EICHOR
● Recruiting
A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus
Condition: Pancreatic Cancer · Pancreatic Neoplasms · Diabetes Mellitus · Sponsor: Nuvance Health
About this study
The main goal of this study is to explore the relationship between new-onset diabetes mellitus/deteriorating diabetes and a subsequent diagnosis of pancreatic cancer. Magnetic Resonance Imaging and Magnetic cholangiopancreatography (MRI/MRCP) will be utilized to screen for early stage pancreatic cancer or precursor lesions. Participants will be asked to donate a blood sample at specific intervals for the creation of a bio-bank necessary for the development of a blood based screening test for pancreatic cancer.
This description comes directly from the study's public registry record.
Talk to the study team
Tammy Lo, MSN · 203-855-3551 · Tammy.Lo@nuvancehealth.org
Pramila Krumholtz, MSN · 203-739-7997 · Pramila.Krumholtz@nuvancehealth.org
Always discuss trial participation with your own doctor first.
Locations (2)
| Yale University | New Haven, Connecticut, United States | Not Yet Recruiting |
| Nuvance Health | Norwalk, Connecticut, United States | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03937453